Bloomsbury Publishing PLC
22 July 2026
BLOOMSBURY PUBLISHING PLC
("Bloomsbury" or "the Company")
$1.5bn Anthropic Settlement Approved
The US District Court has formally approved the settlement of $1.5bn in the class action of Bartz et al vs. Anthropic pertaining to Anthropic training its AI models on content it had not purchased. Bloomsbury confirms that it is among the beneficiaries of the Anthropic settlement and will receive settlement spread over several payments estimated to start in the second half of the financial year.
The Court has listed 14,087 Bloomsbury titles as within the settlement and the proposed settlement is for about $3,000 for each work (less attorney fees and other expenses as described in the court document in the link below) to be divided equally between the author and the publisher.
Bloomsbury had £29.2m net cash as at 28 February 2026. Bloomsbury's capital allocation priorities are organic investment, debt repayment to reduce interest costs, dividend payments and bolt-on acquisition opportunities.
Please see court document: https://lunch.publishersmarketplace.com/wp-content/uploads/2026/07/SettlementApproval.pdf
For further information, please contact:
|
Bloomsbury Publishing Plc |
|
|
Tamsin Garrity, Group Investor Relations Director |
|
|
Hudson Sandler |
|
|
Dan de Belder / Emily Brooker |
Disclaimer
The information in this announcement has not been audited or otherwise independently verified and no representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained herein. None of the Company or any of its affiliates, advisors or representatives shall have any liability whatsoever (in negligence or otherwise) for any loss whatsoever arising from any use of this announcement, or its contents, or otherwise arising in connection with this announcement.
This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares of the Company.
Certain statements, statistics and projections in this announcement are or may be forward looking. By their nature, forward‑looking statements involve a number of risks, uncertainties or assumptions that may or may not occur and actual results or events may differ materially from those expressed or implied by the forward-looking statements. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Accordingly, forward-looking statements contained in this announcement regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. You should not place undue reliance on forward-looking statements, which are based on the knowledge and information available only at the date of this announcement's preparation.
The Company does not undertake any obligation to update or keep current the information contained in this announcement, including any forward‑looking statements, or to correct any inaccuracies which may become apparent and any opinions expressed in it are subject to change without notice.
References in this announcement to other reports or materials, such as a website address, have been provided to direct the reader to other sources of information on Bloomsbury Publishing Plc which may be of interest. Neither the content of Bloomsbury's website nor any website accessible by hyperlinks from Bloomsbury's website nor any additional materials contained or accessible thereon, are incorporated in, or form part of, this announcement.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
ENDRNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.